MPO and colitis: EVs derived from MSCs showed a proper therapeutic effect in a rat colitis model by decreasing myeloperoxidase (MPO) activity, malondialdehyde (MDA) and apoptosis (caspase-3, caspase-8 and caspase-9) [58].